Cryopreservation of human whole blood for pyrogenicity testing

Stefanie Schindler, Silvia Asmus, Sonja Von Aulock, Albrecht Wendel, Thomas Hartung, Stefan Fennrich

Research output: Contribution to journalArticle

Abstract

Human whole blood assays are increasingly employed to test immune function or detect pyrogenic contamination, since they offer advantages, such as ease of performance, few preparation artifacts and a physiological cell environment. However, the approach is often limited by the availability of freshly drawn blood, putative safety concerns in the case of infected donors and interindividual donor differences. To overcome these limitations, a method was developed and optimized to produce batches of cryopreserved blood that can be used directly after thawing without any washing steps. Mononuclear cells remained intact as shown by FACS analysis. Cytokine release could be induced by a variety of immunological stimuli. The cell preparation released higher amounts of interleukin-1β (IL-1β) and IL-6 compared to fresh blood, but no TNF. These differences could be attributed to the presence of the cryoprotectant dimethylsulfoxide (DMSO) alone by addition of DMSO to fresh blood. Large batches of cryopreserved blood could be produced by mixing blood donations of up to 10 donors, independent of differing blood groups. The detection limit for the World Health Organization (WHO) lipopolysaccharides (endotoxin, LPS) reference preparation (EC-6) with regard to the induction of IL-1β release was at least 0.5 endotoxin equivalent units (EU)/ml. Endotoxin spikes at the limit concentrations prescribed in the European Pharmacopoeia could be detected in a series of drugs, showing that the In vitro Pyrogen Test (IPT) can also be run with cryopreserved blood. Further possible applications include high-throughput screening for immunomodulators or toxins as well as preservation of patient samples for later analysis of cell functions.

Original languageEnglish (US)
Pages (from-to)89-100
Number of pages12
JournalJournal of Immunological Methods
Volume294
Issue number1-2
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Cryopreservation
Endotoxins
Tissue Donors
Dimethyl Sulfoxide
Interleukin-1
Blood Safety
Pyrogens
Pharmacopoeias
Immunologic Factors
Blood Group Antigens
Blood Donors
Artifacts
Lipopolysaccharides
Limit of Detection
Interleukin-6
Cytokines
Pharmaceutical Preparations

Keywords

  • Blood
  • Cryopreservation
  • Endotoxin
  • In vitro Pyrogen Test (IPT)
  • Interleukin-1β

ASJC Scopus subject areas

  • Biotechnology
  • Immunology

Cite this

Schindler, S., Asmus, S., Von Aulock, S., Wendel, A., Hartung, T., & Fennrich, S. (2004). Cryopreservation of human whole blood for pyrogenicity testing. Journal of Immunological Methods, 294(1-2), 89-100. https://doi.org/10.1016/j.jim.2004.08.019

Cryopreservation of human whole blood for pyrogenicity testing. / Schindler, Stefanie; Asmus, Silvia; Von Aulock, Sonja; Wendel, Albrecht; Hartung, Thomas; Fennrich, Stefan.

In: Journal of Immunological Methods, Vol. 294, No. 1-2, 11.2004, p. 89-100.

Research output: Contribution to journalArticle

Schindler, S, Asmus, S, Von Aulock, S, Wendel, A, Hartung, T & Fennrich, S 2004, 'Cryopreservation of human whole blood for pyrogenicity testing', Journal of Immunological Methods, vol. 294, no. 1-2, pp. 89-100. https://doi.org/10.1016/j.jim.2004.08.019
Schindler, Stefanie ; Asmus, Silvia ; Von Aulock, Sonja ; Wendel, Albrecht ; Hartung, Thomas ; Fennrich, Stefan. / Cryopreservation of human whole blood for pyrogenicity testing. In: Journal of Immunological Methods. 2004 ; Vol. 294, No. 1-2. pp. 89-100.
@article{b9820c7b0d004304892be5bb256a975e,
title = "Cryopreservation of human whole blood for pyrogenicity testing",
abstract = "Human whole blood assays are increasingly employed to test immune function or detect pyrogenic contamination, since they offer advantages, such as ease of performance, few preparation artifacts and a physiological cell environment. However, the approach is often limited by the availability of freshly drawn blood, putative safety concerns in the case of infected donors and interindividual donor differences. To overcome these limitations, a method was developed and optimized to produce batches of cryopreserved blood that can be used directly after thawing without any washing steps. Mononuclear cells remained intact as shown by FACS analysis. Cytokine release could be induced by a variety of immunological stimuli. The cell preparation released higher amounts of interleukin-1β (IL-1β) and IL-6 compared to fresh blood, but no TNF. These differences could be attributed to the presence of the cryoprotectant dimethylsulfoxide (DMSO) alone by addition of DMSO to fresh blood. Large batches of cryopreserved blood could be produced by mixing blood donations of up to 10 donors, independent of differing blood groups. The detection limit for the World Health Organization (WHO) lipopolysaccharides (endotoxin, LPS) reference preparation (EC-6) with regard to the induction of IL-1β release was at least 0.5 endotoxin equivalent units (EU)/ml. Endotoxin spikes at the limit concentrations prescribed in the European Pharmacopoeia could be detected in a series of drugs, showing that the In vitro Pyrogen Test (IPT) can also be run with cryopreserved blood. Further possible applications include high-throughput screening for immunomodulators or toxins as well as preservation of patient samples for later analysis of cell functions.",
keywords = "Blood, Cryopreservation, Endotoxin, In vitro Pyrogen Test (IPT), Interleukin-1β",
author = "Stefanie Schindler and Silvia Asmus and {Von Aulock}, Sonja and Albrecht Wendel and Thomas Hartung and Stefan Fennrich",
year = "2004",
month = "11",
doi = "10.1016/j.jim.2004.08.019",
language = "English (US)",
volume = "294",
pages = "89--100",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Cryopreservation of human whole blood for pyrogenicity testing

AU - Schindler, Stefanie

AU - Asmus, Silvia

AU - Von Aulock, Sonja

AU - Wendel, Albrecht

AU - Hartung, Thomas

AU - Fennrich, Stefan

PY - 2004/11

Y1 - 2004/11

N2 - Human whole blood assays are increasingly employed to test immune function or detect pyrogenic contamination, since they offer advantages, such as ease of performance, few preparation artifacts and a physiological cell environment. However, the approach is often limited by the availability of freshly drawn blood, putative safety concerns in the case of infected donors and interindividual donor differences. To overcome these limitations, a method was developed and optimized to produce batches of cryopreserved blood that can be used directly after thawing without any washing steps. Mononuclear cells remained intact as shown by FACS analysis. Cytokine release could be induced by a variety of immunological stimuli. The cell preparation released higher amounts of interleukin-1β (IL-1β) and IL-6 compared to fresh blood, but no TNF. These differences could be attributed to the presence of the cryoprotectant dimethylsulfoxide (DMSO) alone by addition of DMSO to fresh blood. Large batches of cryopreserved blood could be produced by mixing blood donations of up to 10 donors, independent of differing blood groups. The detection limit for the World Health Organization (WHO) lipopolysaccharides (endotoxin, LPS) reference preparation (EC-6) with regard to the induction of IL-1β release was at least 0.5 endotoxin equivalent units (EU)/ml. Endotoxin spikes at the limit concentrations prescribed in the European Pharmacopoeia could be detected in a series of drugs, showing that the In vitro Pyrogen Test (IPT) can also be run with cryopreserved blood. Further possible applications include high-throughput screening for immunomodulators or toxins as well as preservation of patient samples for later analysis of cell functions.

AB - Human whole blood assays are increasingly employed to test immune function or detect pyrogenic contamination, since they offer advantages, such as ease of performance, few preparation artifacts and a physiological cell environment. However, the approach is often limited by the availability of freshly drawn blood, putative safety concerns in the case of infected donors and interindividual donor differences. To overcome these limitations, a method was developed and optimized to produce batches of cryopreserved blood that can be used directly after thawing without any washing steps. Mononuclear cells remained intact as shown by FACS analysis. Cytokine release could be induced by a variety of immunological stimuli. The cell preparation released higher amounts of interleukin-1β (IL-1β) and IL-6 compared to fresh blood, but no TNF. These differences could be attributed to the presence of the cryoprotectant dimethylsulfoxide (DMSO) alone by addition of DMSO to fresh blood. Large batches of cryopreserved blood could be produced by mixing blood donations of up to 10 donors, independent of differing blood groups. The detection limit for the World Health Organization (WHO) lipopolysaccharides (endotoxin, LPS) reference preparation (EC-6) with regard to the induction of IL-1β release was at least 0.5 endotoxin equivalent units (EU)/ml. Endotoxin spikes at the limit concentrations prescribed in the European Pharmacopoeia could be detected in a series of drugs, showing that the In vitro Pyrogen Test (IPT) can also be run with cryopreserved blood. Further possible applications include high-throughput screening for immunomodulators or toxins as well as preservation of patient samples for later analysis of cell functions.

KW - Blood

KW - Cryopreservation

KW - Endotoxin

KW - In vitro Pyrogen Test (IPT)

KW - Interleukin-1β

UR - http://www.scopus.com/inward/record.url?scp=10344243492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10344243492&partnerID=8YFLogxK

U2 - 10.1016/j.jim.2004.08.019

DO - 10.1016/j.jim.2004.08.019

M3 - Article

C2 - 15604019

AN - SCOPUS:10344243492

VL - 294

SP - 89

EP - 100

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -